Tg Therapeutics reported $1.65M in Interest Expense on Debt for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Interest Expense On Debt Change
Amgen AMGN:US USD 415M 47M
Biogen BIIB:US USD 59.9M 5.9M
Gilead Sciences GILD:US USD 227M 2M
Infinity Pharmaceuticals INFI:US USD 45K 0
Intercept Pharmaceuticals ICPT:US USD 5.24M 1.43M
Karyopharm Therapeutics KPTI:US USD 6.11M 199K
Novartis NOVN:VX USD 215M 13M
Ptc Therapeutics PTCT:US USD 19.48M 2.8M
Regeneron Pharmaceuticals REGN:US USD 15.3M 2.2M
Roche Holding ROG:VX 256M 90M
Tg Therapeutics TGTX:US USD 1.65M 1.37M
Verastem VSTM:US USD 717K 77K
Vertex Pharmaceuticals VRTX:US USD 13.7M 900K